Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H29NO |
Molecular Weight | 371.5146 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC\C(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
InChI
InChIKey=NKANXQFJJICGDU-QPLCGJKRSA-N
InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-
Molecular Formula | C26H29NO |
Molecular Weight | 371.5146 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:32:00 UTC 2023
by
admin
on
Fri Dec 15 15:32:00 UTC 2023
|
Record UNII |
094ZI81Y45
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
L02BA01
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
||
|
LIVERTOX |
NBK548902
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
||
|
NCI_THESAURUS |
C1821
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
||
|
NCI_THESAURUS |
C2089
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.3
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
||
|
NDF-RT |
N0000175826
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
||
|
NDF-RT |
N0000000168
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
||
|
WHO-VATC |
QL02BA01
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m10450
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | Merck Index | ||
|
Tamoxifen
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
6782
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
3299
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
SUB10825MIG
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
094ZI81Y45
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
10324
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID1034187
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
D013629
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
2561
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
DB00675
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
10540-29-1
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
727681
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
TAMOXIFEN
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
234-118-0
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
41774
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
2733526
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
1016
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
094ZI81Y45
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
CHEMBL83
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
C62078
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY | |||
|
100000091546
Created by
admin on Fri Dec 15 15:32:00 UTC 2023 , Edited by admin on Fri Dec 15 15:32:00 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> INHIBITOR |
Binding Assay
IC50
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TRANSPORTER -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
MINOR
URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||